Biomea Fusion BMEA
NASDAQ BMEA
$1.37 +0.01 (+0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Research & Development (2020 - 2026)

Biomea Fusion (BMEA) posted Research & Development of $9.1 million for Q1 2026, up 12.38% sequentially from $8.1 million in Q4 2025, and down 60.17% YoY from $22.9 million in Q1 2025.

Biomea Fusion (BMEA) Research & Development (2020 - 2026) Analysis & Trends

Biomea Fusion has reported Research & Development for 7 years, with the latest figure at $9.1 million in Q1 2026.

  • Quarterly Research & Development fell 60.17% year-over-year to $9.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48.2 million (down 55.04% YoY) and the FY2025 annual result came in at $62.0 million, down 47.51% from the prior year.
  • Research & Development climbed to $9.1 million in Q1 2026 per BMEA's latest filing, from $8.1 million in the prior quarter.
  • Over five years, Research & Development peaked at $33.8 million in Q1 2024 and troughed at $8.1 million in Q4 2025.
  • A 5-year average of $20.8 million and a median of $21.9 million in 2023 frame the typical range for Research & Development.
  • The sharpest annual moves came in 2022 and 2025: Research & Development jumped 198.84% in 2022, then plunged 67.85% in 2025.
  • Over 5 years, Research & Development stood at $20.5 million in 2022, then jumped by 50.28% to $30.9 million in 2023, then slipped by 18.23% to $25.2 million in 2024, then slumped by 67.85% to $8.1 million in 2025, then rose by 12.38% to $9.1 million in 2026.
  • According to Business Quant data, Research & Development over the past three periods registered $9.1 million, $8.1 million, and $14.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 993.80 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.63 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 651.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 612.28 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 413.13 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -588.31 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 210.03 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 97.90 Mn
10 Biomea Fusion 97.69 Mn 97.69 Mn - 9.14 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 9.14 Mn
Mar 31, 2026 9.12 Mn
Dec 31, 2025 8.12 Mn
Sep 30, 2025 14.40 Mn
Jun 30, 2025 16.57 Mn
Mar 31, 2025 22.90 Mn
Dec 31, 2024 25.24 Mn
Sep 30, 2024 27.24 Mn
Jun 30, 2024 31.83 Mn
Mar 31, 2024 33.78 Mn
Dec 31, 2023 30.87 Mn
Sep 30, 2023 25.35 Mn
Jun 30, 2023 21.94 Mn
Mar 31, 2023 24.40 Mn
Dec 31, 2022 20.54 Mn
Sep 30, 2022 18.24 Mn
Jun 30, 2022 12.58 Mn
Mar 31, 2022 11.35 Mn
Dec 31, 2021 11.09 Mn
Sep 30, 2021 7.89 Mn